IL13 and Eczematoid dermatitis: Serum proteomic analysis revealed that patients with paradoxical eczema already exhibit AD-like inflammatory signatures even before the clinical phenotype manifests, evidenced by enrichment of gene sets related to Th2 cytokines such as IL-4 and IL-13 (32).